Want to see HK:1863 full AI Analyst Report?
1863 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Positive Revenue GrowthReported revenue growth indicates the company continues to expand its top line, providing a foundation for future operating leverage and reinvestment. Although recent annual revenue has been volatile, the positive growth measure remains a constructive indicator of ongoing business activity.
Growing Equity BaseA growing equity base provides a stronger capital foundation for continued operations and investment. The absence of a distressed balance-sheet assessment is also constructive, suggesting the company retains some capacity to manage obligations despite rising leverage and weaker returns.
Operating Cash Flow RecoveryThe recovery in operating cash flow during 2024–2025 shows that the business has been able to restore cash generation after a weak 2023 period. This supports ongoing operations and investment, although the recovery remains less compelling because cash conversion is still modest.
Bears Say
Margin And Profit CompressionDeteriorating margins and lower operating profit indicate reduced earnings quality and weaker operating leverage. The trend may limit the company’s ability to convert revenue growth into durable profit expansion, while also reducing internal funds available for investment and balance-sheet improvement.
Rising LeverageThe substantial rise in debt-to-equity reduces financial flexibility and increases the sensitivity of results to weaker earnings. Higher leverage can constrain capital allocation, make balance-sheet repair more important, and leave less room to absorb continued profitability pressure over coming quarters.
Weak Cash Flow QualityRepeatedly negative or barely positive free cash flow points to inconsistent cash conversion and limits the company’s ability to fund growth or obligations internally. Volatility from reinvestment and working-capital swings makes reported profitability less dependable as a measure of financial strength.
China Longevity Group Co. Ltd. News
1863 FAQ
What was China Longevity Group Co. Ltd.’s price range in the past 12 months?
Currently, no data Available
What is China Longevity Group Co. Ltd.’s market cap?
Currently, no data Available
When is China Longevity Group Co. Ltd.’s upcoming earnings report date?
China Longevity Group Co. Ltd.’s upcoming earnings report date is Mar 31, 2027 which is in 174 days.
How were China Longevity Group Co. Ltd.’s earnings last quarter?
China Longevity Group Co. Ltd. released its earnings results on Aug 31, 2026. The company reported HK$0.028 earnings per share for the quarter.
Is China Longevity Group Co. Ltd. overvalued?
According to Wall Street analysts China Longevity Group Co. Ltd.’s price is currently Overvalued.
Does China Longevity Group Co. Ltd. pay dividends?
China Longevity Group Co. Ltd. pays a Annually dividend of HK$0.1 which represents an annual dividend yield of 5.03%. See more information on China Longevity Group Co. Ltd. dividends here
What is China Longevity Group Co. Ltd.’s EPS estimate?
China Longevity Group Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Longevity Group Co. Ltd. have?
China Longevity Group Co. Ltd. has 852,612,500 shares outstanding.
What happened to China Longevity Group Co. Ltd.’s price movement after its last earnings report?
China Longevity Group Co. Ltd. reported an EPS of HK$0.028 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of China Longevity Group Co. Ltd.?
Currently, no hedge funds are holding shares in HK:1863
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China Longevity Group Co. Ltd.
China Longevity Group operates within the reinforced materials industry, engaging comprehensively in the design, development, production, and distribution of its specialized products. These offerings include advanced polymer-processed polyester fabric composite materials, diverse reinforced composites, conventional materials, and a range of inflatable and waterproof items. The company's versatile products find widespread application across numerous sectors, such as outdoor recreation, sports, renewable energy, protective equipment, construction, transportation, packaging, medical uses, safety solutions, advertising, and everyday consumer goods. Its commercial reach extends globally, with a notable presence in China, the USA, Russia, and various other international markets.
Perfect Medical Health Management Limited
―
EC Healthcare
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―